PROSPECT II Trial investigated the natural progression of unstable atherosclerotic coronary artery disease, with a focus on assessing the effectiveness of low-risk intracoronary imaging techniques, IVUS and NIRS, in identifying plaques that are likely to rupture and cause future clinical events.